PULM vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

PULM

55.2
AI Score
VS
PULM Wins

CBIO

49.1
AI Score

Investment Advisor Scores

PULM

55score
Recommendation
STRONG BUY

CBIO

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PULM CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -99.9% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.2/100 49.1/100 PULM
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD PULM

Relative Price Performance (Last 90 Days)

PULM 1M: -11.4% · 3M: -10.3% CBIO 1M: -10.0% · 3M: -24.3%

Current Technical Phase

PULM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $1.48

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 39

RSI (14): 39.2 · Price: $12.82

Fundamentals Snapshot

Metric PULM CBIO
Market Cap — —
Forward P/E 0.0 -4.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin -12.7% 1.0%
Operating Margin 0.0% -14.3%
EPS -1.10 -7.62
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PULM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.